TWiV 988: Clinical update with Dr. Daniel Griffin

<p><!-- wp:paragraph --></p> <p>In his weekly clinical update Dr. Griffin discusses FDA authorizing the first over-the-counter at-home test to detect both influenza and COVID-19, monoclonal antibody for the prevention of respiratory syncytial virus infection in infants and children, epidemiologic characteristics of SARS-CoV-2 recombinant variant XBB.1.5, COVID-19 vaccines vs pediatric hospitalization, maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life, immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children, fatal fulminant cerebral edema in six children with SARS-CoV-2 Omicron BA.2 infection in Taiwan, certifying deaths due to COVID-19, efficacy of first dose of COVID-19 vaccine vs no vaccination on symptoms of <strong>patients</strong> with long COVID, and the effect of COVID-19 vaccination on long COVID.</p> <p><!-- /wp:paragraph --><!-- wp:html --></p> <p>Subscribe (free): <a title= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784" href= "https://podcasts.apple.com/us/podcast/this-week-in-virology/id1176779065">Apple Podcasts</a>, <a href= "https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <p><!-- /wp:html --><!-- wp:html --></p> <p><!-- /wp:html --><!-- wp:paragraph --></p> <p><!-- /wp:paragraph --><!-- wp:paragraph --></p> <p><!-- /wp:paragraph --><!-- wp:heading {"level":3} --></p> <h3 id="links-for-this-episode"><strong>Links for this episode</strong></h3> <p><!-- /wp:heading --><!-- wp:list --></p> <ul><!-- wp:list-item --> <li><a href= "https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-over-counter-home-test-detect-both-influenza-and-covid-19-viruses"> FDA authorizes</a> over-the-counter